By Erica Ho, Senior Research and Education Associate Post-transplant cancer (PTC) is one of the leading causes of death among organ and tissue transplant recipients. This is because the immunosuppressive medicines recipients need to take to prevent graft rejection weakens their immune system, increasing their risk of developing cancer by 2-3 times compared to the general population.1 However, many cancers, if detected early enough, can be treated and transplant recipients can continue living long and …
